| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.091 | 0.07 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.094 | 0.08 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.29 | 0.08 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.08 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |